Target intelligence / Profile preview

Francisella tularensis antigens (F. tularensis antigens)

Target
F. tularensis antigens
Molecular classification
Bacterial protein, Lipopolysaccharide, Antigen
01

Overview

Francisella tularensis antigens encompass a variety of molecular components, including lipopolysaccharides (LPS) and outer membrane proteins such as FopA, Tul4, and IglC (Sjöstedt, 2003). These molecules are essential for the bacterium's virulence and survival within host macrophages, facilitating the evasion of host defenses (Gunn & Ernst, 2007). These antigens are the primary focus for the development of vaccines and diagnostic assays aimed at Tularemia, a highly infectious disease caused by this Gram-negative coccobacillus (Sjöstedt, 2006). The LPS of F. tularensis is unique in its structure, contributing to the pathogen's ability to evade detection by the host's Toll-like receptors, thereby delaying the innate immune response (Hajjar et al., 2006). Therapeutic strategies targeting these antigens primarily involve the development of live-attenuated or subunit vaccines designed to stimulate robust T-cell mediated immunity (Conlan, 2011). This cellular response is crucial for clearing intracellular infections where antibodies alone may be insufficient. Given its status as a Tier 1 select agent and potential biothreat, understanding and targeting these antigens is a priority for both clinical medicine and biodefense research (Dennis et al., 2001).

Other names
Tularemia antigensF. tularensis surface proteinsFrancisella lipopolysaccharideO-antigenTul4FopAIglCDVC-FT
02

Mechanism of action

Induction of protective humoral and cellular immune responses through activation of B-cells and T-cells (Conlan, 2011).

03

Biological functions

Immune responsePathogenesisIntracellular survivalHost cell attachment
04

Disease associations

InfectionTularemia
05

Safety considerations

High virulence of parent organismRisk of laboratory-acquired infectionPotential for incomplete protectionInflammatory side effects from LPS-based components
06

Interacting drugs

Live Vaccine Strain (LVS)

2 more in the full profile.

07

Biomarkers

Anti-Francisella tularensis antibodiesFrancisella tularensis lipopolysaccharideIglC protein levels

Beyond the preview

Go deeper on Francisella tularensis antigens (F. tularensis antigens).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Francisella tularensis antigens (F. tularensis antigens).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call